Somerset West, Western Cape

Post-harvest processing built to EU-GMP principles, for medicinal cannabis export

A specialist post-harvest facility that will transform GACP-compliant cannabis flower into medicinal cannabis products processed to EU-GMP principles — from cultivation partner to international market.

Processing room with stainless-steel workbenches, chairs and processing equipment
  • EU-GMPBuilt to EU-GMP principles
  • GACPGACP-compliant supplier requirements
  • SAHPRASAHPRA licence application in progress
  • TraceabilityBatch traceability by design

Who We Are

From farm to global pharmaceutical market

The Delta-Nine team at the facility

Delta-Nine Pharmaceuticals is a specialist post-harvest cannabis processing company based in Somerset West, Western Cape. We will partner with GACP-certified cultivation suppliers, selected through our supplier qualification process and operating under Quality/Technical Agreements, purchasing GACP-compliant cannabis flower and adding pharmaceutical value through a facility designed for GMP compliance.

Our mission is to ensure every processed batch meets the highest global standards for quality, safety, and consistency — enabling South African cultivators to access premium international markets with confidence.

  • Drying, trimming, curing, and precision sorting
  • Pharmaceutical-grade weighing, packaging, and secure storage
  • Controlled, GDP-aligned local and export logistics
  • Strict batch traceability and quality assurance throughout

What We Do

End-to-end post-harvest processing services

01

Trimming & Sorting

Precision trimming and grading of cannabis flower to pharmaceutical specifications, ensuring uniformity and quality for every batch destined for global markets.

02

Drying & Curing

Controlled environment drying and curing processes designed to preserve terpene profiles and cannabinoid integrity, and designed to meet strict moisture and microbiological standards.

03

Packaging & Labelling

Packaging, once licensed, under controlled GMP procedures in tamper-evident, pharmaceutical-grade containers with labelling in line with applicable regulatory requirements for the destination market.

04

Secure Storage

Climate-controlled, secure vaulted storage with environmental monitoring and full chain-of-custody documentation from intake through to dispatch.

05

Quality Assurance

In-process testing and batch release procedures, once licensed, will be aligned with EU-GMP (EudraLex Volume 4) principles, with full documentation packages for regulatory submissions.

06

Export Logistics

Once licensed, we will provide end-to-end export coordination including temperature-controlled transport, permits, and regulatory documentation for international pharmaceutical markets.

Laboratory glassware and a pipette on a white bench
White freight truck on a highway

How It Works

The journey from flower to export

  1. Step 01

    Cultivator Partnership

    We will source from GACP-certified cultivation suppliers, selected through our supplier qualification process and operating under Quality/Technical Agreements, verifying licence and GACP documentation before intake.

  2. Step 02

    Intake & Verification

    Once licensed, every incoming batch will be weighed, documented, and tested before entering our controlled processing environment. Batch records will be opened and chain of custody will begin.

  3. Step 03

    Processing

    Drying, curing, trimming, sorting, and grading will be performed in our facility, designed to pharmaceutical-grade standards, under controlled and monitored environmental conditions.

  4. Step 04

    Packaging & Release

    Once licensed, finished product will be packaged to EU-GMP specifications, labelled for target markets, and batch-released by our Responsible Pharmacist with full documentation.

  5. Step 05

    Global Export

    Temperature-controlled logistics, import permits, and regulatory documentation will be coordinated for delivery to international pharmaceutical markets worldwide.

Door to Curing Room 2

Our Milestones

Our road to licensing and EU-GMP

  1. 2024

    Company Established

    Delta-Nine Pharmaceuticals incorporated in South Africa. Facility site selection and initial planning commenced in Somerset West, Western Cape.

    Completed
  2. Early 2025

    Facility Build-Out

    Processing facility constructed to pharmaceutical-grade specifications. Quality Management System development and SOP drafting initiated.

    Completed
  3. Q2 2026

    SAHPRA Licence Application

    Application submitted to SAHPRA in June 2026. Facility inspection readiness and compliance review underway.

    In Progress
  4. Cultivator supplier qualification

    In Progress
  5. Late October 2026

    SAHPRA site inspection scheduled for late October 2026

    Scheduled
  6. First commercial batches: following SAHPRA licence award

    Commencement of commercial post-harvest processing for GACP-certified cultivation suppliers, selected through our supplier qualification process and operating under Quality/Technical Agreements. Initial batch records, QA protocols and supply agreements activated.

    Target
  7. Q1 2027

    EU-GMP audit proposed for January 2027, subject to the authority's confirmation

    Target

Standards & Compliance

Built on the highest global standards

its not personal, its GMP

Our facility and processes are designed from the ground up to meet the rigorous requirements of both South African and international pharmaceutical regulators — so that product can be prepared to meet export market requirements.

Our operations are designed to meet SAHPRA licensing requirements and EU-GMP guidelines, with quality management, batch traceability, and environmental monitoring designed into every stage.

  • Processing rooms designed to Grade D
  • Designed to EU-GMP principles
  • SAHPRA licence application in progress
Corridor lined with change room doors
01

GACP Intake Verification

All incoming flower will be verified against the supplier's SAHPRA licence and GACP documentation before acceptance into our facility.

02

Controlled Processing Environment

Processing rooms and controlled zones designed to Grade D, to maintain pharmaceutical-grade environmental conditions throughout processing.

03

Batch Traceability

Batch records will be kept from intake to release, designed to provide traceability for every unit produced.

04

Regulatory Release

Once licensed, batch release by our Responsible Pharmacist, with documentation packages prepared for target market submissions.

Get in Touch

Partner with us for global reach

Whether you're a GACP-compliant cultivator interested in becoming an approved supplier, or an international buyer seeking supply from a facility working towards EU-GMP certification, we'd like to hear from you.

Location
Somerset West, Western Cape

Privacy notice

Delta-Nine Pharmaceuticals (Pty) Ltd collects the personal information you submit here (such as your name, email address, company and message) only to respond to your enquiry and manage our business relationship with you. We will not sell your information or share it with third parties except where required by law or to service providers who process it on our behalf under confidentiality obligations. We keep it only as long as needed for this purpose. You may ask to access, correct or delete your information, or object to its processing, by contacting our Information Officer through the contact details on this website. You also have the right to lodge a complaint with the Information Regulator (South Africa).